Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma.
| Autor: | Siegel AB, Cohen EI, Ocean A, Lehrer D, Goldenberg A, Knox JJ, Chen H, Clark-Garvey S, Weinberg A, Mandeli J, Christos P, Mazumdar M, Popa E, Brown RS Jr, Rafii S, Schwartz JD, Siegel, Abby B, Cohen, Emil I, Ocean, Allyson, Lehrer, Deborah |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 6/20/2008, Vol. 26 Issue 18, p2992-2998, 7p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|